Gili Kenet Selected Research

Gili Kenet Research Topics

Disease

67	Hemorrhage 04/2024 - 12/2002
56	Hemophilia A (Haemophilia) 04/2024 - 01/2006
22	Thrombosis (Thrombus) 01/2023 - 07/2008
18	Thrombophilia 03/2024 - 10/2004
16	Venous Thromboembolism 03/2024 - 09/2012
8	Hemophilia B (Haemophilia B) 05/2023 - 09/2016
7	Neoplasms (Cancer) 10/2023 - 01/2006
6	Thrombocytopenia (Thrombopenia) 11/2022 - 03/2011
6	Thromboembolism 11/2022 - 12/2009
4	Protein C Deficiency 03/2024 - 01/2009
4	Protein S Deficiency (Deficiency, Protein S) 03/2024 - 04/2010
4	Wounds and Injuries (Trauma) 01/2022 - 12/2002
4	Stroke (Strokes) 01/2013 - 01/2005
3	von Willebrand Diseases (von Willebrand's Disease) 11/2023 - 01/2021
3	Choroidal Neovascularization 06/2023 - 01/2019
3	Inflammation (Inflammations) 11/2022 - 05/2012
3	Venous Thrombosis (Deep-Vein Thrombosis) 10/2020 - 10/2011
3	Thrombasthenia (Glanzmann Thrombasthenia) 01/2019 - 09/2018
3	Ischemic Stroke 12/2009 - 01/2007
2	Thrombotic Microangiopathies 12/2023 - 11/2022
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 12/2023 - 10/2019
2	Factor VII Deficiency (Hypoproconvertinemia) 12/2023 - 07/2003
2	Hypertension (High Blood Pressure) 05/2023 - 01/2014
2	Hypersensitivity (Allergy) 01/2023 - 12/2018
2	Pulmonary Embolism 01/2022 - 11/2016
2	Metrorrhagia (Spotting) 09/2021 - 01/2020
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2021 - 12/2017
2	Hemarthrosis 01/2021 - 01/2017
2	Neonatal Alloimmune Thrombocytopenia 12/2018 - 08/2017
2	Infections 03/2015 - 07/2008
2	Sepsis (Septicemia) 01/2015 - 12/2002
2	Necrosis 01/2015 - 02/2009
2	Disseminated Intravascular Coagulation 01/2015 - 07/2008
1	Injection Site Reaction 12/2023
1	Noonan Syndrome (Female Pseudo-Turner Syndrome) 11/2023
1	Epistaxis (Nosebleed) 11/2023
1	Disease Susceptibility (Diathesis) 11/2023
1	Cholelithiasis 05/2023

Drug/Important Bio-Agent (IBA)

23	Factor VIII (Coagulation Factor VIII)IBA 04/2024 - 01/2013
18	Hemostatics (Antihemorrhagics)IBA 11/2023 - 12/2002
16	emicizumabIBA 04/2024 - 11/2019
13	AntithrombinsIBA 03/2024 - 01/2009
13	AnticoagulantsIBA 03/2024 - 09/2012
13	Thrombin FDA Link 11/2023 - 07/2008
12	Protein CIBA 01/2021 - 01/2009
11	Prothrombin (Factor II)IBA 03/2024 - 01/2005
10	Blood Coagulation Factors (Coagulation Factor)IBA 03/2024 - 07/2008
10	Factor VIIa (Activated Factor VII)IBA 01/2024 - 12/2002
9	recombinant FVIIa (rFVIIa)FDA Link 01/2020 - 12/2002
8	AntibodiesIBA 12/2023 - 04/2011
8	RivaroxabanIBA 11/2022 - 12/2016
7	factor V LeidenIBA 03/2024 - 01/2005
7	Protein SIBA 01/2018 - 01/2009
6	Factor IX (Coagulation Factor IX)FDA LinkGeneric 04/2020 - 09/2016
5	Vitamin K FDA Link 01/2022 - 07/2008
5	Antiphospholipid AntibodiesIBA 10/2017 - 01/2009
4	Blood Group Antigens (Blood Groups)IBA 12/2023 - 02/2021
4	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 11/2022 - 06/2010
4	Heparin (Liquaemin)FDA LinkGeneric 11/2022 - 06/2017
3	6-pyruvoyltetrahydropterin synthase (PTPS)IBA 01/2024 - 01/2020
3	Factor XI (Plasma Thromboplastin Antecedent)IBA 01/2024 - 10/2007
3	BAY 94-9027IBA 01/2024 - 05/2020
3	human F8 protein FDA Link 01/2023 - 01/2020
3	Fibrinogen (Factor I)FDA Link 01/2022 - 05/2011
3	AlbuminsIBA 04/2020 - 09/2016
3	Proteins (Proteins, Gene)FDA Link 04/2020 - 01/2006
2	Valoctocogene RoxaparvovecIBA 04/2024 - 01/2023
2	Small Interfering RNA (siRNA)IBA 03/2024 - 05/2023
2	fitusiranIBA 03/2024 - 05/2023
2	TESIBA 12/2023 - 11/2022
2	recombinant factor VIII N8IBA 11/2023 - 01/2023
2	InflammasomesIBA 06/2023 - 11/2022
2	3K3A-APC proteinIBA 06/2023 - 11/2022
2	Retinaldehyde (Retinal)IBA 11/2022 - 01/2019
2	Inosine Triphosphate (ITP)IBA 01/2021 - 12/2017
2	Recombinant Fusion ProteinsIBA 04/2020 - 09/2016
2	von Willebrand FactorIBA 09/2019 - 01/2013
2	Surface-Active Agents (Surfactants)IBA 01/2018 - 11/2013
2	Factor V (Coagulation Factor V)IBA 01/2018 - 04/2014
2	anti-inhibitor coagulant complexIBA 01/2018 - 01/2017
2	ChitosanIBA 05/2017 - 03/2014
2	vinyltriethoxysilane (VTES)IBA 11/2016 - 01/2006
2	SteroidsIBA 05/2012 - 06/2010
2	ORALIT (ORS)IBA 10/2011 - 04/2010
2	Asparaginase (Elspar)FDA Link 06/2010 - 03/2009
2	Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA 01/2009 - 01/2005
1	Chromogenic CompoundsIBA 04/2024
1	factor VII clotting antigenIBA 12/2023
1	Factor VII (Proconvertin)IBA 12/2023
1	Estrogens (Estrogen)FDA Link 10/2023

Therapy/Procedure

39	Therapeutics 04/2024 - 10/2003
6	Catheters 04/2021 - 03/2015
4	Operative Surgical Procedures 11/2023 - 09/2018
4	Central Venous Catheters 10/2020 - 03/2015
3	Minor Surgical Procedures (Minor Surgery) 11/2019 - 01/2017
3	Platelet Transfusion (Blood Platelet Transfusions) 01/2019 - 01/2018
2	Duration of Therapy 05/2023 - 03/2019
2	Drug Therapy (Chemotherapy) 01/2022 - 03/2015
2	Injections 04/2020 - 09/2016
1	Ligation 12/2023